Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | $425.15M | 28,862,601 | 57.21% | 42.79% | Net Buying | Net Selling | ||
| ZYME | ZYMEWORKS INC | $1.91B | 74,836,534 | 52.65% | 47.35% | Net Buying | |||
| GANX | GAIN THERAPEUTICS INC | $149.44M | 36,097,536 | 12.03% | 3.61% | ||||
| MRP | MILLROSE PROPERTIES INC | $5.26B | 166,003,497 | 64.26% | 0.24% | Net Buying | Net Buying | ||
| SMLR | SEMLER SCIENTIFIC INC | $272.42M | 15,159,895 | 62.99% | 37.01% | Net Buying | Net Buying | ||
| BSVN | BANK7 CORP | $416.80M | 9,453,390 | 12.30% | 87.70% | Net Selling | Net Selling | ||
| MNPR | MONOPAR THERAPEUTICS | $498.55M | 6,682,584 | 18.47% | 81.53% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $704.19M | 59,076,259 | 55.51% | 44.49% | Net Buying | Net Buying | ||
| RWT | REDWOOD TRUST INC | $709.42M | 126,682,210 | 76.56% | 4.32% | Net Buying | |||
| COYA | COYA THERAPEUTICS INC | $129.31M | 20,924,456 | 22.73% | 10.32% | Net Buying | |||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | 71,358,638 | 40.58% | 59.42% | Net Buying | Net Buying | ||
| CYBN | CYBIN INC | $153.86M | 23,033,127 | 39.83% | 0.00% | ||||
| SMWB | SIMILARWEB LTD | $645.40M | 86,283,483 | 52.99% | 0.00% | ||||
| AVBP | ARRIVENT BIOPHARMA INC | $1.01B | 41,281,361 | 78.59% | 21.41% | Net Buying | |||
| CEVA | CEVA INC | $524.31M | 24,017,805 | 69.22% | 30.78% | Net Buying | |||
| ICHR | ICHOR HOLDINGS LTD | $612.73M | 34,384,231 | 68.63% | 31.37% | Net Buying | Net Buying | ||
| PRCH | PORCH GROUP INC | $1.23B | 123,683,561 | 61.81% | 38.19% | Net Selling | Net Selling | ||
| RAPT | RAPT THERAPEUTICS INC | $1.02B | 27,710,871 | 29.99% | 70.01% | ||||
| EVMN | EVOMMUNE INC | $567.75M | 31,524,093 | 0.00% | 49.18% | Net Buying | Net Buying | ||
| BCC | BOISE CASCADE CO | $2.83B | 37,043,073 | 47.49% | 52.51% | Net Selling | |||
| TBPH | THERAVANCE BIOPHARMA INC | $920.72M | 50,672,431 | 52.91% | 47.09% | Net Selling | Net Selling | ||
| GPCR | STRUCTURE THERAPEUTICS INC | $4.06B | 182,032,920 | 31.11% | 11.89% | Net Selling | Net Selling | ||
| SNTI | SENTI BIOSCIENCES INC | $34.44M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| SGMT | SAGIMET BIOSCIENCES INC | $202.61M | 32,521,599 | 36.57% | 63.43% | Net Selling | Net Selling | ||
| XNCR | XENCOR INC | $1.18B | 71,410,469 | 72.07% | 27.93% | Net Selling | |||
| PSN | PARSONS CORP | $6.74B | 106,488,582 | 98.77% | 1.23% | Net Selling | |||
| NTSK | NETSKOPE INC | $8.15B | 393,258,861 | 35.83% | 11.95% | Net Buying | Net Buying | ||
| SSTI | SOUNDTHINKING INC | $96.38M | 12,698,453 | 58.20% | 34.82% | Net Selling | Net Selling | ||
| XOMA | XOMA ROYALTY CORP | $312.30M | 12,383,103 | 18.93% | 81.07% | Net Selling | Net Buying | ||
| CRVO | CERVOMED INC | $78.19M | 9,252,719 | 2.96% | 97.04% | Net Buying | Net Buying | ||
| FBRX | FORTE BIOSCIENCES INC | $267.70M | 12,526,935 | 62.69% | 37.31% | Net Selling | Net Selling | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.45B | 71,949,027 | 75.16% | 24.84% | Net Buying | Net Buying | ||
| MPLT | MAPLIGHT THERAPEUTICS INC | $939.22M | 45,373,033 | 0.00% | 53.72% | Net Buying | Net Buying | ||
| Q | QNITY ELECTRONICS INC | $16.54B | 209,463,194 | 0.00% | 0.11% | Net Buying | Net Buying | ||
| RIOT | RIOT PLATFORMS INC | $5.69B | 371,807,186 | 69.61% | 14.18% | Net Selling | Net Selling | ||
| PHR | PHREESIA INC | $979.66M | 60,287,003 | 78.77% | 21.23% | Net Selling | Net Selling | ||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $139.76M | 55,903,513 | 2.90% | 0.00% | ||||
| BMEA | BIOMEA FUSION INC | $99.69M | 70,703,639 | 35.45% | 24.54% | Net Buying | Net Buying | ||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| JBIO | JADE BIOSCIENCES INC | $689.14M | 46,004,205 | 62.53% | 37.47% | Net Buying | Net Buying | ||
| FUFU | BITFUFU INC | $469.42M | 164,131,946 | 0.62% | 2.07% | ||||
| ATR | APTARGROUP INC | $7.97B | 65,619,154 | 92.09% | 3.79% | Net Selling | |||
| PTRN | PATTERN GROUP INC | $2.24B | 176,224,923 | 11.52% | 88.48% | Net Selling | Net Selling | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.61B | 77,592,130 | 71.39% | 28.61% | Net Selling | Net Selling | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $3.56B | 134,447,836 | 90.30% | 9.70% | Net Selling | Net Selling | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.58B | 59,547,781 | 35.04% | 4.41% | Net Buying | |||
| IMUX | IMMUNIC INC | $74.82M | 120,284,724 | 35.49% | 13.20% | Net Buying | |||
| BITF | BITFARMS LTD | $1.54B | 563,007,747 | 31.30% | 0.00% | ||||
| BRSL | BRIGHTSTAR LOTTERY PLC | $3.11B | 195,000,000 | 44.92% | 0.00% | ||||
| KYTX | KYVERNA THERAPEUTICS INC | $384.53M | 43,796,170 | 50.31% | 49.69% | ||||
| BHVN | BIOHAVEN LTD | $1.22B | 105,855,155 | 78.09% | 21.91% | Net Buying | Net Buying | ||
| CCCC | C4 THERAPEUTICS INC | $239.38M | 96,914,418 | 54.21% | 18.64% | Net Selling | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $1.21B | 53,372,098 | 62.03% | 37.97% | Net Buying | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | 97,389,279 | 83.32% | 16.68% | Net Selling | Net Selling | ||
| CLFD | CLEARFIELD INC | $410.19M | 13,839,096 | 61.23% | 38.77% | Net Selling | Net Selling | ||
| AIRO | AIRO GROUP HOLDINGS INC | $266.08M | 31,303,834 | 24.89% | 34.70% | Net Selling | |||
| IMTX | IMMATICS NV | $1.22B | 121,563,829 | 76.04% | 0.00% | ||||
| RZLT | REZOLUTE INC | $166.91M | 92,727,532 | 44.67% | 55.33% | Net Buying | |||
| TIGR | UP FINTECH HOLDING LTD | $1.64B | 2,656,878,202 | 2.70% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.